These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16429832)

  • 41. The evolution of the manufacturing science and the pharmaceutical industry.
    Politis SN; Rekkas DM
    Pharm Res; 2011 Jul; 28(7):1779-81. PubMed ID: 21584843
    [No Abstract]   [Full Text] [Related]  

  • 42. Examples of NIR based real time release in tablet manufacturing.
    Skibsted ET; Westerhuis JA; Smilde AK; Witte DT
    J Pharm Biomed Anal; 2007 Mar; 43(4):1297-305. PubMed ID: 17166686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative overview of indoor air quality in Antwerp, Belgium.
    Stranger M; Potgieter-Vermaak SS; Van Grieken R
    Environ Int; 2007 Aug; 33(6):789-97. PubMed ID: 17399789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biopharmaceuticals and the future of the pharmaceutical industry.
    Lowe JA; Jones P
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):513-4. PubMed ID: 17786848
    [No Abstract]   [Full Text] [Related]  

  • 45. [Role of the pharmaceutical industry in the Belgian economy].
    Vermeesch L
    Bull Mem Acad R Med Belg; 2004; 159(10-12):501-2. PubMed ID: 16035624
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharma industry in India.
    Sundaram VM
    Drug News Perspect; 2008; 21(1):59-63. PubMed ID: 18301810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Know your suppliers--a study in contrasts.
    J Am Pharm Assoc; 1969 Aug; 9(8):426-9. PubMed ID: 5799732
    [No Abstract]   [Full Text] [Related]  

  • 48. Abbott and Tecan announce agreement for molecular diagnostics technology.
    Pharmacogenomics; 2003 Jan; 4(1):10. PubMed ID: 14658429
    [No Abstract]   [Full Text] [Related]  

  • 49. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Future developments in the pharmaceutical industry].
    Kleemann A
    Pharm Unserer Zeit; 1996 Nov; 25(6):298-9. PubMed ID: 9082454
    [No Abstract]   [Full Text] [Related]  

  • 51. Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities.
    Lin AY; Tsai YT
    Sci Total Environ; 2009 Jun; 407(12):3793-802. PubMed ID: 19345984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of the routes of bacterial contamination occurring during aseptic pharmaceutical manufacturing.
    Whyte W; Bailey PV; Tinkler J; McCubbin I; Young L; Jess J
    J Parenter Sci Technol; 1982; 36(3):102-7. PubMed ID: 7097451
    [No Abstract]   [Full Text] [Related]  

  • 53. Does the European pharmaceutical industry have a future?
    McKillop T
    Circulation; 2006 Feb; 113(5):f19-20. PubMed ID: 16468149
    [No Abstract]   [Full Text] [Related]  

  • 54. Airborne particulate matter and BTEX in office environments.
    Horemans B; Worobiec A; Buczynska A; Van Meel K; Van Grieken R
    J Environ Monit; 2008 Jul; 10(7):867-76. PubMed ID: 18688455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 56. Distribution characteristics of airborne bacteria and fungi in the feedstuff-manufacturing factories.
    Kim KY; Kim HT; Kim D; Nakajima J; Higuchi T
    J Hazard Mater; 2009 Sep; 169(1-3):1054-60. PubMed ID: 19481347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmaceutical industry in pediatric drug development: partners and collaborators with academia and the FDA.
    Mulberg AE
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):711-3. PubMed ID: 18955888
    [No Abstract]   [Full Text] [Related]  

  • 58. Particulate matter and gaseous pollutants in residences in Antwerp, Belgium.
    Stranger M; Potgieter-Vermaak SS; Van Grieken R
    Sci Total Environ; 2009 Jan; 407(3):1182-92. PubMed ID: 19012947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and construction of a dedicated clinical supply facility: an example of effective project management.
    Rothrock C
    J Parenter Sci Technol; 1983; 37(5):186-90. PubMed ID: 6655536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.